Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NDA submission for palonosetron for chemotherapy-induced nausea and vomiting on track

May 8, 2002

Merck presents newest inhibitors of farnesyl- and geranylgeranyltransferases

May 7, 2002

Antitumor activity reported by SRI for benzopyran-based enzyme inhibitors

May 7, 2002

PK-11195 may be effective in improving clinical outcomes in acute myeloid leukemia

May 7, 2002

Integrin receptor antagonists and their use reported by Pharmacia

May 6, 2002

Fast track designation for oxaliplatin

May 6, 2002

IND approved for TRAIL-R1 MAb

May 6, 2002

Ad-p53-transduced dendritic cells provide effective immunization and cancer treatment

May 6, 2002

New antitumor compounds isolated by scientists at Nippon Kayaku

May 6, 2002

Inex releases positive interim results for Onco TCS in small cell lung cancer trial

May 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...